The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pelvic Floor Diagnostic Market Research Report 2024

Global Pelvic Floor Diagnostic Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1766173

No of Pages : 102

Synopsis
Pelvic floor diagnostic tests are procedures used to evaluate the function and condition of the pelvic floor muscles. The pelvic floor refers to a group of muscles and connective tissues located in the pelvic area that support the pelvic organs, including the bladder, uterus, and rectum.

Global Pelvic Floor Diagnostic market is projected to reach US$ 2805.5 million in 2029, increasing from US$ 1967 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pelvic Floor Diagnostic market research.

The growth of the pelvic floor diagnostics industry is primarily associated with the growing prevalence of pelvic floor disorders globally and rising healthcare expenditure. The developments of technologically advanced diagnostic systems and government support have led to a surge in demand for reliable and extensive diagnostic systems.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pelvic Floor Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • LABORIE
  • CooperSurgical
  • SRS Medical
  • Medtronic
  • MEDSPIRA
  • Albyn Medical
  • PENTAX Medical
  • Olympus Medical Systems
  • Stryker
  • EndoMed Systems
  • Richard Wolf
  • Schölly Fiberoptic
  • Zhuhai Seesheen Medical Technology
  • KARL STORZ
  • Cadwell
  • The Prometheus Group
  • Neurosoft

Segment by Type

  • Pelvic Floor Muscle Examination
  • Electromyography
  • Pelvic Ultrasound
  • Urodynamic Testing
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Pelvic Floor Diagnostic report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pelvic Floor Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pelvic Floor Muscle Examination
1.2.3 Electromyography
1.2.4 Pelvic Ultrasound
1.2.5 Urodynamic Testing
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pelvic Floor Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pelvic Floor Diagnostic Market Perspective (2018-2029)
2.2 Pelvic Floor Diagnostic Growth Trends by Region
2.2.1 Global Pelvic Floor Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pelvic Floor Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Pelvic Floor Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 Pelvic Floor Diagnostic Market Dynamics
2.3.1 Pelvic Floor Diagnostic Industry Trends
2.3.2 Pelvic Floor Diagnostic Market Drivers
2.3.3 Pelvic Floor Diagnostic Market Challenges
2.3.4 Pelvic Floor Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pelvic Floor Diagnostic Players by Revenue
3.1.1 Global Top Pelvic Floor Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Pelvic Floor Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Pelvic Floor Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pelvic Floor Diagnostic Revenue
3.4 Global Pelvic Floor Diagnostic Market Concentration Ratio
3.4.1 Global Pelvic Floor Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pelvic Floor Diagnostic Revenue in 2022
3.5 Pelvic Floor Diagnostic Key Players Head office and Area Served
3.6 Key Players Pelvic Floor Diagnostic Product Solution and Service
3.7 Date of Enter into Pelvic Floor Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pelvic Floor Diagnostic Breakdown Data by Type
4.1 Global Pelvic Floor Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Pelvic Floor Diagnostic Forecasted Market Size by Type (2024-2029)
5 Pelvic Floor Diagnostic Breakdown Data by Application
5.1 Global Pelvic Floor Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Pelvic Floor Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pelvic Floor Diagnostic Market Size (2018-2029)
6.2 North America Pelvic Floor Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pelvic Floor Diagnostic Market Size by Country (2018-2023)
6.4 North America Pelvic Floor Diagnostic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pelvic Floor Diagnostic Market Size (2018-2029)
7.2 Europe Pelvic Floor Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pelvic Floor Diagnostic Market Size by Country (2018-2023)
7.4 Europe Pelvic Floor Diagnostic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pelvic Floor Diagnostic Market Size (2018-2029)
8.2 Asia-Pacific Pelvic Floor Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pelvic Floor Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Pelvic Floor Diagnostic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pelvic Floor Diagnostic Market Size (2018-2029)
9.2 Latin America Pelvic Floor Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pelvic Floor Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Pelvic Floor Diagnostic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pelvic Floor Diagnostic Market Size (2018-2029)
10.2 Middle East & Africa Pelvic Floor Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pelvic Floor Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Pelvic Floor Diagnostic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LABORIE
11.1.1 LABORIE Company Detail
11.1.2 LABORIE Business Overview
11.1.3 LABORIE Pelvic Floor Diagnostic Introduction
11.1.4 LABORIE Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.1.5 LABORIE Recent Development
11.2 CooperSurgical
11.2.1 CooperSurgical Company Detail
11.2.2 CooperSurgical Business Overview
11.2.3 CooperSurgical Pelvic Floor Diagnostic Introduction
11.2.4 CooperSurgical Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.2.5 CooperSurgical Recent Development
11.3 SRS Medical
11.3.1 SRS Medical Company Detail
11.3.2 SRS Medical Business Overview
11.3.3 SRS Medical Pelvic Floor Diagnostic Introduction
11.3.4 SRS Medical Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.3.5 SRS Medical Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Pelvic Floor Diagnostic Introduction
11.4.4 Medtronic Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.4.5 Medtronic Recent Development
11.5 MEDSPIRA
11.5.1 MEDSPIRA Company Detail
11.5.2 MEDSPIRA Business Overview
11.5.3 MEDSPIRA Pelvic Floor Diagnostic Introduction
11.5.4 MEDSPIRA Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.5.5 MEDSPIRA Recent Development
11.6 Albyn Medical
11.6.1 Albyn Medical Company Detail
11.6.2 Albyn Medical Business Overview
11.6.3 Albyn Medical Pelvic Floor Diagnostic Introduction
11.6.4 Albyn Medical Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.6.5 Albyn Medical Recent Development
11.7 PENTAX Medical
11.7.1 PENTAX Medical Company Detail
11.7.2 PENTAX Medical Business Overview
11.7.3 PENTAX Medical Pelvic Floor Diagnostic Introduction
11.7.4 PENTAX Medical Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.7.5 PENTAX Medical Recent Development
11.8 Olympus Medical Systems
11.8.1 Olympus Medical Systems Company Detail
11.8.2 Olympus Medical Systems Business Overview
11.8.3 Olympus Medical Systems Pelvic Floor Diagnostic Introduction
11.8.4 Olympus Medical Systems Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.8.5 Olympus Medical Systems Recent Development
11.9 Stryker
11.9.1 Stryker Company Detail
11.9.2 Stryker Business Overview
11.9.3 Stryker Pelvic Floor Diagnostic Introduction
11.9.4 Stryker Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.9.5 Stryker Recent Development
11.10 EndoMed Systems
11.10.1 EndoMed Systems Company Detail
11.10.2 EndoMed Systems Business Overview
11.10.3 EndoMed Systems Pelvic Floor Diagnostic Introduction
11.10.4 EndoMed Systems Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.10.5 EndoMed Systems Recent Development
11.11 Richard Wolf
11.11.1 Richard Wolf Company Detail
11.11.2 Richard Wolf Business Overview
11.11.3 Richard Wolf Pelvic Floor Diagnostic Introduction
11.11.4 Richard Wolf Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.11.5 Richard Wolf Recent Development
11.12 Schölly Fiberoptic
11.12.1 Schölly Fiberoptic Company Detail
11.12.2 Schölly Fiberoptic Business Overview
11.12.3 Schölly Fiberoptic Pelvic Floor Diagnostic Introduction
11.12.4 Schölly Fiberoptic Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.12.5 Schölly Fiberoptic Recent Development
11.13 Zhuhai Seesheen Medical Technology
11.13.1 Zhuhai Seesheen Medical Technology Company Detail
11.13.2 Zhuhai Seesheen Medical Technology Business Overview
11.13.3 Zhuhai Seesheen Medical Technology Pelvic Floor Diagnostic Introduction
11.13.4 Zhuhai Seesheen Medical Technology Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.13.5 Zhuhai Seesheen Medical Technology Recent Development
11.14 KARL STORZ
11.14.1 KARL STORZ Company Detail
11.14.2 KARL STORZ Business Overview
11.14.3 KARL STORZ Pelvic Floor Diagnostic Introduction
11.14.4 KARL STORZ Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.14.5 KARL STORZ Recent Development
11.15 Cadwell
11.15.1 Cadwell Company Detail
11.15.2 Cadwell Business Overview
11.15.3 Cadwell Pelvic Floor Diagnostic Introduction
11.15.4 Cadwell Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.15.5 Cadwell Recent Development
11.16 The Prometheus Group
11.16.1 The Prometheus Group Company Detail
11.16.2 The Prometheus Group Business Overview
11.16.3 The Prometheus Group Pelvic Floor Diagnostic Introduction
11.16.4 The Prometheus Group Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.16.5 The Prometheus Group Recent Development
11.17 Neurosoft
11.17.1 Neurosoft Company Detail
11.17.2 Neurosoft Business Overview
11.17.3 Neurosoft Pelvic Floor Diagnostic Introduction
11.17.4 Neurosoft Revenue in Pelvic Floor Diagnostic Business (2018-2023)
11.17.5 Neurosoft Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’